Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ADALIMUMAB
- Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration.
- Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease
- A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study
- Effects of TNF Blockade on Human BPH/LUTS
- Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa
- A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- Study Evaluation of the Efficacy, Safety and Immunogenicity of Adalimumab in Comparison With Humira®
- Effect of Adalimumab Therapy on Psoriasis Patient
- A Study of Adalimumab on Inflammatory Mediators Following a Systemic Endotoxin Challenge
- "Comparison of the Efficacy and Safety of Adalimumab to That of Tocilizumab in Severe Uveitis of Behçet's Disease"
- Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis
- Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis
- Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis
- Biologic Therapy in Pediatric JIA Uveitis
- Biologics and Blistering
- The Clinical Efficacy and the Changes of Immune Cells Subsets With Bioagents in Ankylosing Spondylitis Patients
- Januse Kinase Inhibition With Filgotinib to Silence Autoreactive B Cells in Rheumatoid Arthritis
- Efficacy of a Sequential Treatment Strategy in Rheumatoid Arthritis
- A Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Participants Requiring High Dose Corticosteroids for Active Non-Infectious Intermediate, Posterior, or Pan-Uveitis
- Study of the Efficacy and Safety of AMT-101 in Combination With Adalimumab in Subjects With Ulcerative Colitis (MARKET)
- Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa
- Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events
- CD40L Antagonism in Rheumatoid Arthritis (RA)
- Stand UP to Rheumatoid Arthritis (SUPRA)
- The Anti-Freaze-F Study- "Anti-TNF for Treatment of Frozen Shoulder - a Feasibility Study"
- Infliximab and Adalimumab in Irritable Bowel Disease Patients.
- BARIcitinib Cognitive Emotional and Neural signaTuRE
- Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative Colitis
- Assessment of Safety , Clinical Efficacy With QLETLI in Non-infectious Uveitis (UV)
- Study to Compare PK & Safety of Advixa With Humira in Healthy, Adult Subject Followed by Efficacy & Safety Study in RA Patients
- Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy
- Early Changes in Pain, Disease Activity, and Ultrasound Evidence of Inflammatory Synovitis in Patients Receiving JAK-inhibitor vs. TNF-inhibitor Therapy for Active Rheumatoid Arthritis: A Feasibility Study.
- Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis
- To Compare the Pharmacokinetics and Safety of PBP1502 and Humira in Healthy Subjects
- Efficacy and Safety of Adalimumab Plus Medium Dose Oral Glucocorticosteroid for Refractory Behçet's Uveitis
- Experimental Medicine Studies of Brain and Peripheral Immune Mechanisms for Sickness Behaviours in Patients With Rheumatoid Arthritis
- COVID-19 VaccinE Response in Rheumatology Patients
- A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis
- Safety and Efficacy of Oral BT-11 in Crohn's Disease Patients With Moderate to Severe Disease
- Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial
- The Efficacy and Safety of Adalimumab in Non-infectious Anterior Pediatric Uveitis With Peripheral Vascular Leakage
- A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa
- Better After CHoosing. Randomly Allocated or Patient Preference Based Treatment With Filgotinib or TNFi in RA (BACH)
- A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate
- Clinical Study of Cord Blood Mononuclear Cells on Treatment of Hormone-resistant or Hormone-dependent Ulcerative Colitis
- Evaluation of the Optimal Concentration Range of Adalimumab for Ankylosing Spondylitis in a Prospective Observational Cohort Study
- Combination of Baricitinib and Adalimumab in Rheumatoid Arthritis
- Efficacy, Safety and Costs of Methotrexate, Adalimumab, or Their Combination in Non-infectious Non-anterior Uveitis
- LTX-109 as Treatment for Hidradenitis Suppurativa
- Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients
- Safety and Efficacy of Artesunate & Curcumin in Crohn's Disease
- Study of Adalimumab or Placebo in Patients With Mild to Moderate COVID-19 (COMBAAT)
- A Study of JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's Disease
- A Study to Test Efficacy, Safety, and Pharmacokinetics of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Crohn's Disease
- Cyclophosphamide in the Treatment of Refractory Proliferative Arachnoiditis in CNS Tuberculosis
- Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis
- Adalimumab Plus Methotrexate for the Treatment of Pediatric Uveitis
- Clinical Burden of Anemia in Inflammatory Bowel Disease: Therapeutic Trial
- A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas
- A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
- Pharmacokinetics, Safety, Tolerability, and Immunogenicity of Two Formulations of SB5 in Healthy Male Subjects
- Spondyloarthritis: Inducing Drug-free Remission by Early TNF-alpha Blockade
- Correlation of Serum Adalimumab Levels at an Administration of 40 mg Weekly vs 80 mg Every Two Weeks
- Effect of Two Methotrexate in Sync With the First Adalimumab to Prevent the Immunisation Anti Ada in Spondyloarthritis
- Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients
- Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)
- A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis
- Adalimumab Dose Reduction Aiming Low Serum Concentration With Control of Disease Activity
- Adalimumab Drug Optimisation in Rheumatoid Arthritis Using Therapeutic Drug Monitoring
- A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab
- ADalimumab in Persistent Early Oligoarthrits Study (ADEOS)
- A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira
- Hidradenitis Suppurativa Patient Experience With Humira Treatment
- Loss of Response of Adalimumab Biosimilar vs Adalimumab Original, in Inflammatory Bowel Disease.
- Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy
- A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis
- A Study of Baricitinib in Participants With Rheumatoid Arthritis
- Evaluation of the Safety and Effectiveness of Switching From Humira® to Imraldi® in Flanders
- The Benefit of Bermekimab in Patients With Systemic Sclerosis
- Dose Tapering Study of Adalimumab in Psoriasis
- Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS
- Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease
- PK, Safety and Tolerability Study of AVT02 (Adalimumab) Pre-filled Syringe (PFS) vs, AVT02 Autoinjector (AI)
- Pharmacokinetics and Safety in Healthy Volunteers
- Control Crohn Safe Trial
- A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis
- A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
- Pharmacokinetics, Safety and Tolerability Study of AVT02 to EU-approved and US-licensed Humira (Adalimumab)
- Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- Adalimumab vs. Conventional Immunosuppression for Uveitis Trial
- Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)
- Therapeutic Drug Monitoring of Tocilizumab in Rheumatoid Arthritis
- Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial
- A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)
- Identification by Cytometry by Mass of Predictive Immunological Profiles of Answer to Treatmentby Biotherapics for Patients With Crohn's Disease
- EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis
- Effects of Abatacept on Myocarditis in Rheumatoid Arthritis
- Tofacitinib for Inflammatory Eye Disease
- Comparative Safety, Tolerability, Pharmacokinetic Study of AVT02 (100MG/ML) and Humira (100MG/ML) in Healthy Volunteers
- Prediction of Treatment Response at 6 Months by Combinatorial Analysis of Serum Biomarkers in Biotherapy Naive SpA
- Comparative Clinical Efficacy and Safety of Coded Polyherbal Medicine for the Management of Arthritis
- Evaluation of the Optimal MTX Dose as an Add-on Therapy to Adalimumab for RA Patients in Japan, South Korea and Taiwan
- Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis
- Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
- A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
- Phase I Study of HLX3 vs Adalimumab in Chinese Healthy Subjects
- Study of Efficacy and Safety of HLX03 in Subjects With Moderate to Severe Plaque Psoriasis
- A Study Assessing the Efficacy and Safety of Adalimumab in Active Ulcer(s) of Pyoderma Gangrenosum in Participants in Japan
- Changing the coUrse of cRohn's Disease With an Early Use of Adalimumab
- Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa
- A Study Of CinnoRA (Adalimumab-CinnaGen) And Adalimumab (Humira) In Healthy Subjects
- Efficacy of Combined Fractional Carbon Dioxide Laser and Topical Tazarotene in the Treatment of Psoriatic Nail Disease
- A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa.
- Cost-effectiveness of Adalimumab and Surgery vs Adalimumab in HS
- Autologous Stem Cell Transplant for Crohn's Disease
- MAP Study: Methotrexate and Adalimumab in Psoriasis
- Repurposing Anti-TNF for Treating Dupuytren's Disease
- Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RA
- Climatotherapy Versus Topical Combination of Corticosteroids and Salicylic Acid in Treatment of Psoriasis
- Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I and II
- A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic Arthritis
- Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
- A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
- Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGation
- MSB11022 in Moderate to Severe Rheumatoid Arthritis
- Short-term Safety, Efficacy and Mode of Action of Apremilast in Moderate Suppurative Hidradenitis
- Immunoregulatory Mechanisms of Treg Cells Induced by Tocilizumab
- Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UC
- Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveitis
- A Phase 1 Pharmacokinetic Bioequivalence Study of DMB-3113 and Adalimumab in Healthy Japanese Adult Male Subjects
- Comparative Clinical Trial to Evaluate Bioequivalency and Safety of Monoclonal Antibody Injection and Adalimumab in Chinese Healthy Volunteers
- Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa
- Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis
- Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
- Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"
- Development of a Biomarker of Efficacy of Vedolizumab (EnTyvio®) in Patients With ulcErative ColiTis (DETECT)
- Reduce Risk for Crohn's Disease Patients
- Treatment Tapering in JIA With Inactive Disease
- Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)
- Effectiveness of Vedolizumab in CD Patients Naïve to Anti-TNF
- A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL)
- Safety and Efficacy of Adalimumab (Humira) for Hidradenitis Suppurativa (HS) Peri-Surgically
- Efficacy of CROWN in Repair and Maintenance of the Intestinal Mucosa in Patients With CD Receiving Anti-TNF Therapy
- Triple Combination Therapy in High Risk Crohn's Disease (CD)
- Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease
- Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis
- A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis
- BI 655066/ABBV-066 (Risankizumab) Compared to Active Comparator (Adalimumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis
- Entyvio (Vedolizumab) Long Term Safety Study
- MABp1 IN HIDRADENITIS SUPPURATIVA REFRACTORY TO ADALIMUMAB
- Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis
- Adalimumab in Alleviating Inflammation in Patients With Axial Spondyloarthritis
- A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate
- Diabetes Islet Preservation Immune Treatment
- Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis
- Effect of Prebiotic FOS on Intestinal Abundance of Faecalibacterium Prausnitzii in Patients With Crohn´s Disease
- Study to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)
- A Trial of Adalimumab Combined to Chemotherapy and Radiotherapy in Patients With Anaplastic Thyroid Cancers
- An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
- Biomarkers Identification of Anti-tumor Necrosis Factor (TNF) α Agent's Efficacy in Ankylosing Spondylitis Patients
- Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis
- Osteoarthritis of the Knee, Inflammation, and the Effect of Adalimumab (OKINADA)
- Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis
- Adalimumab Trough Concentrations in Crohn's Disease: A Pilot Pharmacokinetic Study
- Effects of Adalimumab in Mucopolysaccharidosis Types I, II and VI
- Phase 2, Multicenter, Open-Label Extension Study With ABT-122 in Rheumatoid Arthritis Subjects Who Have Completed the Preceding M12-963 Study
- Evaluate if Response to Infliximab or Adalimumab May be Regained With an Immunomodulator
- A Study to Compare FKB327 Long-term Safety, Efficacy and Immunogenicity With Humira® in Rheumatoid Arthritis Patients
- Comparative Clinical Study of Pharmacokinetics, Tolerance and Safety of BCD-057 and Humira in Healthy Volunteers
- Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate
- Treatments Against RA and Effect on FDG-PET/CT
- Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH)
- Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation
- The Efficacy of Denosumab in Active Crohn's Disease
- Salvage Therapy With High/Low Methotrexate for Loss of Response to Infliximab Dose Escalation
- Pediatric Crohn's Disease AdalImumab Level-based Optimization Treatment (PAILOT) Trial
- Effect of Anti-Inflammatory Agents on Biological Responses to Endotoxin Inhalation in Healthy Subjects
- Anti-TNFα Use During Elective Foot and Ankle Surgery in Patients With Rheumatoid Arthritis
- A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment
- A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis
- A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects (PREDICTRA)
- Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study
- An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate
- Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects With Crohn's Disease and Who Participated and Successfully Completed M14-115
- A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors
- A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors
- An Exploratory Genetic Study in Participants With Psoriasis
- The Effect of Adalimumab Plus Methotrexate (MTX) Versus Placebo Plus MTX on Cartilage in (RA) Patients
- BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
- Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
- Clinical Trial Using Humira in Netherton Syndrome
- A Trial Investigating the Mechanism of Action of NNC0109-0012 (Anti-IL-20 mAb) Through Synovial Biopsies in Subjects With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
- Randomised Double-Blind, Placebo-Controlled, Parallel Group Study in Patients With Active Rheumatoid Arthritis:Magnetic Resonance Imaging Sub-Study
- Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
- A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor
- Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis
- Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects With Moderate to Severe Crohn's Disease
- Targeted Ultrasound in Rheumatoid Arthritis
- Pharmacokinetics and Safety in Healthy Volunteers
- Bone Resorption, Osteoclastogenesis and Adalimumab
- A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
- Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
- Adalimumab Intralesional in Intestinal Strictures of Crohn's Disease Patients
- Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to Adalimumab
- A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects.
- Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS)
- Study of Adalimumab to Lower Cardiovascular Risk in RA Patients With Well Controlled Joint Disease
- Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
- Skin Transcriptional Profiles In Psoriatic Patients Under Adalimumab Biotherapy
- Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS)
- Vascular Inflammation in Psoriasis - Extension Study
- Economic Evaluation of Systemic Treatments for Moderate-to-severe Psoriasis
- Stopping TNF Alpha Inhibitors in Rheumatoid Arthritis
- Antibiotics and Hydroxychloroquine in Crohn's
- Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate
- An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
- Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis
- Corticosteroids and Anti TNF in Methotrexate Inadequate Responder Rheumatoid Arthritis Patient
- Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC)
- A Study in Moderate to Severe Rheumatoid Arthritis
- Swiss Dermatology Network of Targeted Therapies (SDNTT)
- Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment of Moderate to Severe Plaque Psoriasis
- A Study of Ixekizumab in Participants With Active Psoriatic Arthritis
- Calprotectin-Directed Humira® Maintenance Therapy (CADHUM)
- Adalimumab in the Treatment of Chronic Pouchitis
- TNF-alfa Inhibitors and Antibody Production in Patients With Psoriasis
- Adalimumab for the Management of Post-operative Crohn's Disease (CD)
- Causes of Visual Loss in Retinal Disease
- Effect of Spacing of Anti-TNF Drugs in Ankylosing Spondylitis With Low Disease Activity
- An Observational Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis And Inadequate Response Or Intolerance to a First Anti-TNF Alpha Therapy
- EUS Evaluation of Perianal and Peri-rectal Fistulizing Crohn's Disease With CERTOLIZUMAB Treatment
- Adalimumab on Preventing Post-chirurgic Recurrence on Crohn´s Disease
- Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants
- Adalimumab-psoriasis and Small Bowel Lesions
- Vascular Inflammation in Psoriasis Trial (The VIP Trial)
- RHYTHM (Formerly Escape II Myocardium)
- Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab
- Safety of Zostavax Vaccination in Rheumatoid Arthritis
- Pharmacokinetics and Safety Study of BI 695501 in Healthy Subjects
- Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
- Efficacy and Safety of Adalimumab for the Induction of Clinical Response in Ulcerative Colitis
- A Study to Evaluate CNTO 1959 in the Treatment of Patients With Moderate to Severe Plaque-type Psoriasis
- HUmira in Psoriatic Arthritis
- Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis
- Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate
- A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)
- Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents
- Switching From Adalimumab to Infliximab
- Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab.
- Efficacy Study of Adalimumab to Treat Interstitial Cystitis
- SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug.
- A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inh
- Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser Endomicroscopy of the Gut
- The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthritis. A Pilot Study.
- Efficacy and Safety of Adalimumab 80 mg Every Other Week With Methotrexate
- Evaluation of Efficacy and Safety of Fostamatinib Monotherapy Compared With Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (RA)
- A Double Blind Study in Pediatric Subjects With Chronic Plaque Psoriasis, Studying Adalimumab vs. Methotrexate
- Evaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After TNF Alfa Inhibitors Therapy
- Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's Disease
- Regulatory T-cells in Psoriasis Patients as Targets for Therapy
- A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy in Patients With Active Rheumatoid Arthritis
- A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
- Pain Modulation in Rheumatoid Arthritis (RA) - Influence of Adalimumab
- Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA)
- A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA)
- Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea
- Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal Healing
- A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis
- A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
- Small Bowel Mucosal Healing Induced by Adalimumab in Crohn's Disease Patients as Assessed by Capsule Endoscopy
- Efficacy and Safety of Adalimumab in Patients With Active Uveitis
- Intravitreal Adalimumab in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
- SMART Study: A Study of Re-treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNF Alfa Therapy
- Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
- A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis
- Repeat Dose Subcutaneous Rhumatoid Arthritis Efficacy Study
- The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis
- A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
- Adalimumab in Axial Spondyloarthritis (ASIM) - MRI and Biomarkers in Patients With Spondyloarthritis
- Adalimumab in Rheumatoid Arthritis. An Investigation of Wholebody MRI, Conventional MRI, CT and Circulating Biomarkers
- Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy
- The Effect of Adalimumab on the Bone Microstructure in Crohn's Disease (CD) Patients
- Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)
- Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments
- A 24 Week Open Label Study of the Utility of Adalimumab in Active Axial Forms of Psoriatic Arthritis
- Mechanism of Action Study for Psoriasis
- Abatacept Versus Adalimumab Head-to-Head
- Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Response to Etanercept
- Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Suppurativa
- A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis
- Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study
- A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis
- A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
- Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
- The Safety & Efficacy of Etanercept in Psoriasis Patients Who Have Not Responded to Adalimumab
- To Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa
- Bone Resorption, Osteoclastogenesis and Adalimumab
- Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial
- A Pilot Study of the Feasibility of Discontinuation of Adalimumab in Stable Rheumatoid Arthritis Patients in Clinical Remission
- A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab
- Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)
- Juvenile Idiopathic Arthritis (JIA) Registry
- Spacing of TNF-blocker Injections in Rheumatoid Arthritis Study
- Active Juvenile Idiopathic Arthritis (JIA) Compassionate Use
- Evaluation of Quality of Life Changes in Puerto Rican Subjects With Active Rheumatoid Arthritis Treated With Humira
- Efficacy and Safety of TAK-783 in Subjects With Rheumatoid Arthritis
- Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis
- Adalimumab in Combination With Ciprofloxacin/Placebo Treatment of Perianal Fistulas in Crohn's
- Efficacy Study of Humira in the Treatment of Cutaneous Sarcoidosis
- Safety and Efficacy Study of Humira in Treatment of Pyoderma Gangrenosum
- Discontinuation of TNF-alpha Inhibitors in Patients With Spondyloarthritis
- A Study of Immune Cells in Patients With Rheumatoid Arthritis During Different Types of Anti-TNF Alpha Treatments (Study P05521)
- Humira in Rheumatoid Arthritis - Do Bone Erosions Heal?
- Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis
- Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma Gangrenosum
- A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNFα Inhibitor Therapy
- Adalimumab for Inflammatory Osteoarthritis
- Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA)
- Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing
- Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderately to Severely Active Psoriatic Arthritis
- Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
- Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy
- Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
- Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
- Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
- Atacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II)
- Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment
- A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis
- Adalimumab (Humira) in the Treatment of Refractory Non-infectious Uveitis
- Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome
- A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Adalimumab in Subjects With Refractory Asthma
- Positron Emission Tomography in Rheumatoid Arthritis With Adalimumab (PETRA)
- Prospective Study on Intensive Early Rheumatoid Arthritis Treatment
- An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY)
- Danish Multicenter Study of Adalimumab in Spondyloarthritis
- Adalimumab in Severe and Acute Sciatica
- A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM)
- Open-Label Adalimumab for Ulcerative Colitis Patients
- Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis
- Evaluation of 2 Oral Doses of PG-760564 in Rheumatoid Arthritis (RA) Patients Receiving Methotrexate
- Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial)
- Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis
- Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to Severe Crohn's Disease With Previous Exposure to Infliximab (CHOICE)
- Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease
- Trial of Adalimumab in Progressive Sarcoidosis
- HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis
- A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)
- Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis
- Study to Evaluate the Efficacy of Adalimumab in Patients With Erosive Osteoarthritis of the Interphalangeal Finger Joints
- Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early Arthritis
- A Study of Adalimumab to Treat Sarcoidosis of the Skin
- A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease
- Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
- Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA)
- Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate
- Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
- D2E7-Early AS
- Quality of Life Study With Adalimumab in Rheumatoid Arthritis
- Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis
- Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheumatoid Arthritis
- Predictors of the Response to Adalimumab in Rheumatoid Arthritis
- Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis
- The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists
- Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis
- Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.
- Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
- Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis
- Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS)
- A Pilot Trial of Adalimumab for the Treatment of Osteoarthritis
- TNFalfa Blocking Treatment of Spondylarthropathies
- Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
- Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease
- A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
- Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis
- Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA)
Clinical trials list
click for details